tiprankstipranks
Trending News
More News >
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Income Statement

Compare
1,276 Followers

Entero Therapeutics Income Statement

Last quarter (Q4 2024), Entero Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Entero Therapeutics's net income was $-12.24M. See Entero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -29.27K$ -106.21K$ -537.40K$ -571.14K
Operating Expenses
$ 15.62K$ 15.77M$ 12.68M$ 56.70M$ 26.43M
Depreciation and Amortization
$ 48.95K$ 29.27K$ 29.27K$ 542.25K$ 565.35K
EBITDA
-$ -15.74M$ -14.51M$ -57.99M$ -26.26M
Operating Income
-$ -15.77M$ -12.68M$ -59.06M$ -26.43M
Other Income/Expenses
-$ -24.16K$ -1.95M$ -1.83M$ -6.24M
Pretax Income
-$ -15.79M$ -14.63M$ -58.54M$ -32.67M
Net Income
$ -18.06M$ -15.79M$ -14.63M$ -58.54M$ -32.67M
Per Share Metrics
Basic EPS
$ -4.62$ -47.88$ -416.93$ -39.77K$ -61.64K
Diluted EPS
$ -4.62$ -47.88$ -416.93$ -39.77K$ -61.64K
Weighted Average Shares Outstanding
3.91M 336.34K 35.91K--
Weighted Average Shares Outstanding (Diluted)
3.43M 336.34K 35.91K--
Currency in USD

Entero Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis